
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Insights, Forecast to 2029
Description
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Insights, Forecast to 2029
Market Analysis and Insights: Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) estimated at US$ 139345 million in the year 2023, is projected to reach a revised size of US$ 217203 million by 2029, growing at a CAGR of 7.68% during the forecast period 2023-2029.
The US & Canada market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from $ 37855 million in 2023 to reach $ 50454 million by 2029, at a CAGR of 4.9% during the forecast period of 2023 through 2029.
The China market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from $ 17129 million in 2023 to reach $ 51175 million by 2029, at a CAGR of 20.01% during the forecast period of 2023 through 2029.
The Europe market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from $ 28502 million in 2023 to reach $ 36462 million by 2029, at a CAGR of 4.19% during the forecast period of 2024 through 2029.
The global key companies of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, etc. In 2022, the global top five players had a share approximately 14.45% in terms of revenue.
Report Includes
This report presents an overview of global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lonza, Catalent, Thermo Fisher Scientific, Aenova, Siegfried, Recipharm, Strides Pharma, Piramal, and Boehringer Ingelheim, etc.
By Company
Catalent
Thermo Fisher Scientific
Lonza
Siegfried
Recipharm
Boehringer Ingelheim
WuXi AppTech
WuXi Biologics
Fareva
Samsung Biologics
Aenova
Delpharm
Strides Pharma
Piramal
Famar
Curia
Jubilant
Vetter
AGC Pharma Chemicals
Asymchem
Porton
Eurofins
Ascendia Pharmaceuticals
Ardena
CPL
UPM Pharmaceuticals
FUJIFILM Diosynth Biotechnologies
Groupe Parima
TBD Pharmatech
Avid Bioservices
NextPharma
Alcami
Societal CDMO
MedPharm
Euroapi
BioVectra
Pfizer CentreOne
Fermion
Lundbeck
Segment by Type
API CDMO
FDF CDMO
Packaging CDMO
Clinical CDMO
Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Asia (Ex. China)
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
China
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Middle East
Africa
Other
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) estimated at US$ 139345 million in the year 2023, is projected to reach a revised size of US$ 217203 million by 2029, growing at a CAGR of 7.68% during the forecast period 2023-2029.
The US & Canada market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from $ 37855 million in 2023 to reach $ 50454 million by 2029, at a CAGR of 4.9% during the forecast period of 2023 through 2029.
The China market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from $ 17129 million in 2023 to reach $ 51175 million by 2029, at a CAGR of 20.01% during the forecast period of 2023 through 2029.
The Europe market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from $ 28502 million in 2023 to reach $ 36462 million by 2029, at a CAGR of 4.19% during the forecast period of 2024 through 2029.
The global key companies of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, etc. In 2022, the global top five players had a share approximately 14.45% in terms of revenue.
Report Includes
This report presents an overview of global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lonza, Catalent, Thermo Fisher Scientific, Aenova, Siegfried, Recipharm, Strides Pharma, Piramal, and Boehringer Ingelheim, etc.
By Company
Catalent
Thermo Fisher Scientific
Lonza
Siegfried
Recipharm
Boehringer Ingelheim
WuXi AppTech
WuXi Biologics
Fareva
Samsung Biologics
Aenova
Delpharm
Strides Pharma
Piramal
Famar
Curia
Jubilant
Vetter
AGC Pharma Chemicals
Asymchem
Porton
Eurofins
Ascendia Pharmaceuticals
Ardena
CPL
UPM Pharmaceuticals
FUJIFILM Diosynth Biotechnologies
Groupe Parima
TBD Pharmatech
Avid Bioservices
NextPharma
Alcami
Societal CDMO
MedPharm
Euroapi
BioVectra
Pfizer CentreOne
Fermion
Lundbeck
Segment by Type
API CDMO
FDF CDMO
Packaging CDMO
Clinical CDMO
Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Asia (Ex. China)
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
China
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Middle East
Africa
Other
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
265 Pages
- 1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis By Type
- 1.2.1 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size Growth Rate By Type: 2018 Vs 2022 Vs 2029
- 1.2.2 Clinical Cdmo
- 1.2.3 Api Cdmo
- 1.2.4 Fdf Cdmo
- 1.2.5 Packaging Cdmo
- 1.3 Market By Application
- 1.3.1 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Application: 2018 Vs 2022 Vs 2029
- 1.3.2 Pharmaceutical Company
- 1.3.3 Biotechnology Company
- 1.4 Assumptions And Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
- 2 Global Growth Trends
- 2.1 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Perspective (2018-2029)
- 2.2 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Growth Trends By Region
- 2.2.1 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Region: 2018 Vs 2022 Vs 2029
- 2.2.2 Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Historic Market Size By Region (2018-2023)
- 2.2.3 Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Forecasted Market Size By Region (2024-2029)
- 2.3 Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Dynamics
- 2.3.1 Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Industry Trends
- 2.3.2 Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Drivers
- 2.3.3 Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Challenges
- 2.3.4 Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Restraints
- 3 Competition Landscape By Key Players
- 3.1 Global Revenue Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) By Players
- 3.1.1 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Revenue By Players (2018-2023)
- 3.1.2 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Revenue Market Share By Players (2018-2023)
- 3.2 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.3 Global Key Players Of Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization), Ranking By Revenue, 2021 Vs 2022
- 3.4 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Concentration Ratio
- 3.4.1 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Concentration Ratio (Cr5 And Hhi)
- 3.4.2 Global Top 10 And Top 5 Companies By Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Revenue In 2022
- 3.5 Global Key Players Of Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Head Office And Production Site
- 3.6 Founded Date Of Global Key Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Players
- 3.7 Mergers & Acquisitions, Expansion Plans
- 4 Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Breakdown Data By Type
- 4.1 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Historic Market Size By Type (2018-2023)
- 4.2 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Forecasted Market Size By Type (2024-2029)
- 5 Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Breakdown Data By Application
- 5.1 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Historic Market Size By Application (2018-2023)
- 5.2 Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Forecasted Market Size By Application (2024-2029)
- 6 North America
- 6.1 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size (2018-2029)
- 6.2 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type
- 6.2.1 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2018-2023)
- 6.2.2 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2024-2029)
- 6.2.3 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Type (2018-2029)
- 6.3 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application
- 6.3.1 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2018-2023)
- 6.3.2 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2024-2029)
- 6.3.3 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Application (2018-2029)
- 6.4 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country
- 6.4.1 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country: 2018 Vs 2022 Vs 2029
- 6.4.2 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country (2018-2023)
- 6.4.3 North America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Country (2024-2029)
- 6.4.4 United States
- 6.4.5 Canada
- 7 Europe
- 7.1 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size (2018-2029)
- 7.2 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type
- 7.2.1 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2018-2023)
- 7.2.2 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2024-2029)
- 7.2.3 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Type (2018-2029)
- 7.3 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application
- 7.3.1 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2018-2023)
- 7.3.2 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2024-2029)
- 7.3.3 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Application (2018-2029)
- 7.4 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country
- 7.4.1 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country: 2018 Vs 2022 Vs 2029
- 7.4.2 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country (2018-2023)
- 7.4.3 Europe Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country (2024-2029)
- 7.4.4 Germany
- 7.4.5 France
- 7.4.6 U.K.
- 7.4.7 Italy
- 7.4.8 Russia
- 8 China
- 8.1 China Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size (2018-2029)
- 8.2 China Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type
- 8.2.1 China Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2018-2023)
- 8.2.2 China Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2024-2029)
- 8.2.3 China Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Type (2018-2029)
- 8.3 China Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application
- 8.3.1 China Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2018-2023)
- 8.3.2 China Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2024-2029)
- 8.3.3 China Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Application (2018-2029)
- 9 Asia (Excluding China)
- 9.1 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size (2018-2029)
- 9.2 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type
- 9.2.1 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2018-2023)
- 9.2.2 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2024-2029)
- 9.2.3 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Type (2018-2029)
- 9.3 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application
- 9.3.1 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2018-2023)
- 9.3.2 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2024-2029)
- 9.3.3 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Application (2018-2029)
- 9.4 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Region
- 9.4.1 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Region: 2018 Vs 2022 Vs 2029
- 9.4.2 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Region (2018-2023)
- 9.4.3 Asia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Region (2024-2029)
- 9.4.4 Japan
- 9.4.5 South Korea
- 9.4.6 Southeast Asia
- 9.4.7 India
- 9.4.8 Australia
- 10 Middle East, Africa, And Latin America
- 10.1 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size (2018-2029)
- 10.2 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type
- 10.2.1 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2018-2023)
- 10.2.2 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Type (2024-2029)
- 10.2.3 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Type (2018-2029)
- 10.3 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application
- 10.3.1 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2018-2023)
- 10.3.2 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Application (2024-2029)
- 10.3.3 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Application (2018-2029)
- 10.4 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country
- 10.4.1 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country: 2018 Vs 2022 Vs 2029
- 10.4.2 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country (2018-2023)
- 10.4.3 Middle East, Africa, And Latin America Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Country (2024-2029)
- 10.4.4 Brazil
- 10.4.5 Mexico
- 10.4.6 Middle East
- 10.4.7 Africa
- 11 Key Players Profiles
- 11.1 Catalent
- 11.1.1 Catalent Company Details
- 11.1.2 Catalent Business Overview
- 11.1.3 Catalent Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.1.4 Catalent Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.1.5 Catalent Recent Development
- 11.2 Thermo Fisher Scientific
- 11.2.1 Thermo Fisher Scientific Company Details
- 11.2.2 Thermo Fisher Scientific Business Overview
- 11.2.3 Thermo Fisher Scientific Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.2.4 Thermo Fisher Scientific Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.2.5 Thermo Fisher Scientific Recent Development
- 11.3 Lonza
- 11.3.1 Lonza Company Details
- 11.3.2 Lonza Business Overview
- 11.3.3 Lonza Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.3.4 Lonza Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.3.5 Lonza Recent Development
- 11.4 Siegfried
- 11.4.1 Siegfried Company Details
- 11.4.2 Siegfried Business Overview
- 11.4.3 Siegfried Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.4.4 Siegfried Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.4.5 Siegfried Recent Development
- 11.5 Recipharm
- 11.5.1 Recipharm Company Details
- 11.5.2 Recipharm Business Overview
- 11.5.3 Recipharm Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.5.4 Recipharm Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.5.5 Recipharm Recent Development
- 11.6 Boehringer Ingelheim
- 11.6.1 Boehringer Ingelheim Company Details
- 11.6.2 Boehringer Ingelheim Business Overview
- 11.6.3 Boehringer Ingelheim Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.6.4 Boehringer Ingelheim Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.6.5 Boehringer Ingelheim Recent Development
- 11.7 Wuxi Apptech
- 11.7.1 Wuxi Apptech Company Details
- 11.7.2 Wuxi Apptech Business Overview
- 11.7.3 Wuxi Apptech Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.7.4 Wuxi Apptech Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.7.5 Wuxi Apptech Recent Development
- 11.8 Wuxi Biologics
- 11.8.1 Wuxi Biologics Company Details
- 11.8.2 Wuxi Biologics Business Overview
- 11.8.3 Wuxi Biologics Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.8.4 Wuxi Biologics Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.8.5 Wuxi Biologics Recent Development
- 11.9 Fareva
- 11.9.1 Fareva Company Details
- 11.9.2 Fareva Business Overview
- 11.9.3 Fareva Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.9.4 Fareva Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.9.5 Fareva Recent Development
- 11.10 Samsung Biologics
- 11.10.1 Samsung Biologics Company Details
- 11.10.2 Samsung Biologics Business Overview
- 11.10.3 Samsung Biologics Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.10.4 Samsung Biologics Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.10.5 Samsung Biologics Recent Development
- 11.11 Aenova
- 11.11.1 Aenova Company Details
- 11.11.2 Aenova Business Overview
- 11.11.3 Aenova Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.11.4 Aenova Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.11.5 Aenova Recent Development
- 11.12 Delpharm
- 11.12.1 Delpharm Company Details
- 11.12.2 Delpharm Business Overview
- 11.12.3 Delpharm Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.12.4 Delpharm Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.12.5 Delpharm Recent Development
- 11.13 Strides Pharma
- 11.13.1 Strides Pharma Company Details
- 11.13.2 Strides Pharma Business Overview
- 11.13.3 Strides Pharma Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.13.4 Strides Pharma Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.13.5 Strides Pharma Recent Development
- 11.14 Piramal
- 11.14.1 Piramal Company Details
- 11.14.2 Piramal Business Overview
- 11.14.3 Piramal Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.14.4 Piramal Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.14.5 Piramal Recent Development
- 11.15 Famar
- 11.15.1 Famar Company Details
- 11.15.2 Famar Business Overview
- 11.15.3 Famar Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.15.4 Famar Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.15.5 Famar Recent Development
- 11.16 Curia
- 11.16.1 Curia Company Details
- 11.16.2 Curia Business Overview
- 11.16.3 Curia Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.16.4 Curia Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.16.5 Curia Recent Development
- 11.17 Jubilant
- 11.17.1 Jubilant Company Details
- 11.17.2 Jubilant Business Overview
- 11.17.3 Jubilant Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.17.4 Jubilant Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.17.5 Jubilant Recent Development
- 11.18 Vetter Pharma
- 11.18.1 Vetter Pharma Company Details
- 11.18.2 Vetter Pharma Business Overview
- 11.18.3 Vetter Pharma Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.18.4 Vetter Pharma Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.18.5 Vetter Pharma Recent Development
- 11.19 Agc Pharma Chemicals
- 11.19.1 Agc Pharma Chemicals Company Details
- 11.19.2 Agc Pharma Chemicals Business Overview
- 11.19.3 Agc Pharma Chemicals Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.19.4 Agc Pharma Chemicals Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.19.5 Agc Pharma Chemicals Recent Development
- 11.20 Asymchem
- 11.20.1 Asymchem Company Details
- 11.20.2 Asymchem Business Overview
- 11.20.3 Asymchem Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.20.4 Asymchem Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.20.5 Asymchem Recent Development
- 11.21 Porton
- 11.21.1 Porton Company Details
- 11.21.2 Porton Business Overview
- 11.21.3 Porton Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.21.4 Porton Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.21.5 Porton Recent Development
- 11.22 Eurofins
- 11.22.1 Eurofins Company Details
- 11.22.2 Eurofins Business Overview
- 11.22.3 Eurofins Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.22.4 Eurofins Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.22.5 Eurofins Recent Development
- 11.23 Ascendia Pharmaceuticals
- 11.23.1 Ascendia Pharmaceuticals Company Details
- 11.23.2 Ascendia Pharmaceuticals Business Overview
- 11.23.3 Ascendia Pharmaceuticals Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.23.4 Ascendia Pharmaceuticals Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.23.5 Ascendia Pharmaceuticals Recent Development
- 11.24 Ardena
- 11.24.1 Ardena Company Details
- 11.24.2 Ardena Business Overview
- 11.24.3 Ardena Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.24.4 Ardena Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.24.5 Ardena Recent Development
- 11.25 Cpl
- 11.25.1 Cpl Company Details
- 11.25.2 Cpl Business Overview
- 11.25.3 Cpl Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.25.4 Cpl Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.25.5 Cpl Recent Development
- 11.26 Upm Pharmaceuticals
- 11.26.1 Upm Pharmaceuticals Company Details
- 11.26.2 Upm Pharmaceuticals Business Overview
- 11.26.3 Upm Pharmaceuticals Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.26.4 Upm Pharmaceuticals Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.26.5 Upm Pharmaceuticals Recent Development
- 11.27 Fujifilm Diosynth Biotechnologies
- 11.27.1 Fujifilm Diosynth Biotechnologies Company Details
- 11.27.2 Fujifilm Diosynth Biotechnologies Business Overview
- 11.27.3 Fujifilm Diosynth Biotechnologies Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.27.4 Fujifilm Diosynth Biotechnologies Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.27.5 Fujifilm Diosynth Biotechnologies Recent Development
- 11.28 Groupe Parima
- 11.28.1 Groupe Parima Company Details
- 11.28.2 Groupe Parima Business Overview
- 11.28.3 Groupe Parima Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.28.4 Groupe Parima Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.29 Tbd Pharmatech
- 11.29.1 Tbd Pharmatech Company Details
- 11.29.2 Tbd Pharmatech Business Overview
- 11.29.3 Tbd Pharmatech Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.29.4 Tbd Pharmatech Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.30 Avid Bioservices
- 11.30.1 Avid Bioservices Company Details
- 11.30.2 Avid Bioservices Business Overview
- 11.30.3 Avid Bioservices Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.30.4 Avid Bioservices Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.31 Nextpharma
- 11.31.1 Nextpharma Company Details
- 11.31.2 Nextpharma Business Overview
- 11.31.3 Nextpharma Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.31.4 Nextpharma Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.31.5 Nextpharma Recent Development
- 11.32 Alcami
- 11.32.1 Alcami Company Details
- 11.32.2 Alcami Business Overview
- 11.32.3 Alcami Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.32.4 Alcami Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.32.5 Alcami Recent Development
- 11.33 Societal Cdmo
- 11.33.1 Societal Cdmo Company Details
- 11.33.2 Societal Cdmo Business Overview
- 11.33.3 Societal Cdmo Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.33.4 Societal Cdmo Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.33.5 Societal Cdmo Recent Development
- 11.34 Medpharm
- 11.34.1 Medpharm Company Details
- 11.34.2 Medpharm Business Overview
- 11.34.3 Medpharm Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.34.4 Medpharm Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.35 Euroapi
- 11.35.1 Euroapi Company Details
- 11.35.2 Euroapi Business Overview
- 11.35.3 Euroapi Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.35.4 Euroapi Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.35.5 Euroapi Recent Development
- 11.36 Biovectra
- 11.36.1 Biovectra Company Details
- 11.36.2 Biovectra Business Overview
- 11.36.3 Biovectra Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.36.4 Biovectra Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.37 Pfizer Centreone
- 11.37.1 Pfizer Centreone Company Details
- 11.37.2 Pfizer Centreone Business Overview
- 11.37.3 Pfizer Centreone Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.37.4 Pfizer Centreone Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.37.5 Pfizer Centreone Recent Development
- 11.38 Fermion
- 11.38.1 Fermion Company Details
- 11.38.2 Fermion Business Overview
- 11.38.3 Fermion Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.38.4 Fermion Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.38.5 Fermion Recent Development
- 11.39 Lundbeck
- 11.39.1 Lundbeck Company Details
- 11.39.2 Lundbeck Business Overview
- 11.39.3 Lundbeck Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Introduction
- 11.39.4 Lundbeck Revenue In Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Business (2018-2023)
- 11.39.5 Lundbeck Recent Development
- 12 Analyst's Viewpoints/Conclusions
- 13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer
- List Of Tables
- Table 1. Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size Growth Rate By Type (Us$ Million): 2018 Vs 2022 Vs 2029
- Table 2. Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size Growth By Application (Us$ Million): 2018 Vs 2022 Vs 2029
- Table 3. Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size Growth Rate (Cagr) By Region (Us$ Million): 2018 Vs 2022 Vs 2029
- Table 4. Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Size By Region (2018-2023) & (Us$ Million)
- Table 5. Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Region (2018-2023)
- Table 6. Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Forecasted Market Size By Region (2024-2029) & (Us$ Million)
- Table 7. Global Pharmaceutical Cdmo (Pharmaceutical Contract Development And Manufacturing Organization) Market Share By Region (2024-2029)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.